Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Multiple cysteine-rich proteins" is a **generic descriptor** rather than a single molecular entity or therapeutic target. Cysteine-rich proteins (CRPs) are a broad and structurally diverse group of small proteins characterized by the presence of many cysteine residues, which can form disulfide bonds for structural stability or coordinate metal ions, allowing them to serve varied roles in biological systems[1]. These proteins are found in bacteria, plants, animals, and humans. Key families include plant CRPs involved in defense and reproduction, cysteine-rich secretory proteins (CRISPs) important in mammalian reproduction and venom activity, and cysteine-rich intestinal proteins (CRIPs) implicated in cancer and cardiovascular biology[3][5][6]. Due to this heterogeneity, "multiple cysteine-rich proteins" does not refer to a single gene, protein, or drug target, making this designation **non-specific, non-canonical, and not a recognized therapeutic target**. --- The term as provided is **incorrect** as a drug or therapeutic target, as it refers to a vast and heterogeneous superfamily of proteins with very different functions across organisms. To retrieve structured and target-specific information, a precise, individual protein or well-defined family name is required (e.g., "Cysteine-rich secretory protein 1" or "Cysteine-rich intestinal protein 2")[1][3][5][6].
Varies by protein/family: - Structural stabilization by disulfide bond formation or metal chelation - Signal transduction via interaction with receptors or transcription factors - Enzyme inhibition (as protease, amylase inhibitors) - Receptor blocking (e.g., venom proteins affecting ion channels)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple cysteine-rich proteins.